Shoghli, Mohammadreza
Sinisalo, Juha
Lokki, A. Inkeri
Lääperi, Mitja
Lokki, Marja-Liisa
Hilvo, Mika
Jylhä, Antti
Tuomilehto, Jaakko
Laaksonen, Reijo
Funding for this research was provided by:
University of Helsinki
Article History
Received: 17 February 2025
Accepted: 25 July 2025
First Online: 15 October 2025
Declarations
:
: The FINRISK 2002 Study was approved by the Epidemiological and Public Health Ethics Committee of the Helsinki Hospital District on 19 December 2001 (Dnro 558/E3/2001). All participants in the study provided their informed consent.
: Not applicable.
: Only Professor Reijo Laaksonen, one of the authors in this study, is a shareholder of Zora Biosciences Oy, which holds related patents. This has not influenced the conduct or outcomes of our research. All findings reported herein are based on objective analysis. All other authors declare no competing interests.